Tessa Gargett

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade

Tessa Gargett, Wenbo Yu, Gianpietro Dotti et al. · Molecular Therapy · 2016 · 349 citations · Full text

Genome-Wide Identification of Human FOXP3 Target Genes in Natural Regulatory T Cells

Timothy Sadlon, Bridget G. Wilkinson, Stephen Pederson et al. · The Journal of Immunology · 2010 · 142 citations · Full text

Genetics, T-regulatory Cell, Immune Regulation +18

Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma

Tessa Gargett, M. Nazim Abbas, Paul Rolan et al. · Cancer Immunology Immunotherapy · 2018 · 108 citations · Full text

Melanoma, Immunology, Tumor Immunity +7

Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2

Tessa Gargett, Michael P. Brown · Cytotherapy · 2015 · 106 citations

Cancer Immunosurveillance, Autoimmune Disease, T-regulatory Cell +12

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

Tessa Gargett, Lisa M. Ebert, Nga Truong et al. · Journal for ImmunoTherapy of Cancer · 2022 · 89 citations · Full text